He is the director of Oncology Institute. Charette at Haddassa Ein hospital Kerem.Provodit active research in the field of oncology, is developing experimental drugs, including those intended for ustrareniya adverse effects arising from the application of chemotherapy
Jablonski Tamar Peretz - Professor, Doctor of Medicine and head of Sharett Institute of Oncology at Hadassah medical center. Active medical practitioners successfully combines with research activities in the framework of which the professor is engaged in in-depth study of oncology, the search formula to create an experimental drug that, according to experts, should exclude the possibility of side effects of chemotherapy. On this topic Dr. Jablonski Tamar Peretz wrote and published more than a hundred papers in reputable journals Israel and other countries.
Professor enters into a variety of specialized communities and associations that raise questions and problems related to cancer treatment.
Conducts research to find innovative methods . treatment of cancer, the development of experimental drugs and eliminate the side effects of chemotherapy
1986 - 1994. - A staff physician, Department of Oncology, University Hospital Hadassah
February 1990 - July 1991. - Head of the outpatient oncology clinic, Hadassah University Hospital
July 1993 - October 1994 - Acting head of the Institute of Oncology Charette;
November 1994 -nast. time - the head of the Oncology Institute of Charette, University Hospital Hadassah, Jerusalem;
Membership Community / Participation in events
The Israeli Medical Association;
The Israeli cancer society;
The Israeli society of medicine and Law;
The Israeli society of surgical Oncology;
The Israeli menopause society research;
Israel company combating breast disease;
The Israeli Society of doctors women;
The American Society of radiation Oncology;
cancer Society in the Middle east;
< li> The American Association for cancer research;
The European society mastologii;
The European society for medical Oncology;
European society of Senology;
The European society cancer research;
The American society of clinical Oncology;
American society for the fight against breast disease;
The Academy of Sciences of New York;
The American Association for the advancement of science;
The Board Alumni New York hospital-Medical center Cornell;
The Company Alumni Memorial hospital
He is the author of over 90 publications in prestigious medical journals in Europe and Israel.
A leading specialist in the diagnosis and treatment of urological and oncological urological diseases in Israel. Provides diagnosis, prevention and treatment of: benign prostatic hyperplasia, prostate cancer, prostatitis. He has extensive experience in the field and carry out complex operations involved in brachytherapy.